Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 11, 2016, Pages 1388-1394

  Burd, Christin E ^a,b   Gill, Matthew S ^c   Niedernhofer, Laura J ^c   Robbins, Paul D ^c   Austad, Steven N ^d   Barzilai, Nir ^e,f   Kirkland, James L ^g  

^a Department of Molecular Genetics ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Division of Endocrinology Department of Pediatrics   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

Author keywords

Aging; Geroscience network; Preclinical drug development

Indexed keywords

AGING; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; GERIATRICS; HUMAN; MEDICAL RESEARCH; ORGANIZATION; PRECLINICAL STUDY; TRENDS;

AGING; ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GERIATRICS; HUMANS;

EID: 84994441052     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glw112     Document Type: Article

References (48)

1. Kenyon CJ. The genetics of ageing. Nature. 2010;464:504-512. doi:10.1038/nature08980
2. Lucanic M, Lithgow GJ, Alavez S. Pharmacological lifespan extension of invertebrates. Ageing Res Rev. 2013;12:445-458. doi:10.1016/j. arr.2012.06.006
3. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392-395. doi:10.1038/nature08221
4. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:461-464. doi:10.1038/366461a0
5. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16:1165-1173. doi:10.1111/dom.12354
6. Xu M, Tchkonia T, Ding H, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci USA. 2015;112:E6301-E6310. doi:10.1073/pnas.1515386112
7. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003;289:2554-2559. doi:10.1001/jama.289.19.2554
8. Richardson A, Fischer KE, Speakman JR, et al. Measures of healthspan as indices of aging in mice-a recommendation. J Gerontol A Biol Sci Med Sci. 2016;71:427-430. doi:10.1093/gerona/glv080
9. Kane AE, Hilmer SN, Boyer D, et al. Impact of longevity interventions on a validated mouse clinical frailty index. J Gerontol A Biol Sci Med Sci. 2016;71:333-339. doi:10.1093/gerona/glu315
10. Warner HR, Ingram D, Miller RA, Nadon NL, Richardson AG. Program for testing biological interventions to promote healthy aging. Mech Ageing Dev. 2000;115:199-207. doi:10.1016/s0047-6374(00)00118-4
11. Nadon NL, Strong R, Miller RA, et al. Design of aging intervention studies: the NIA interventions testing program. Age. 2008;30:187-199. doi:10.1007/s11357-008-9048-1
12. Bogue MA, Peters LL, Paigen B, et al. Accessing data resources in the mouse phenome database for genetic analysis of murine life span and health span. J Gerontol A Biol Sci Med Sci. 2016;71:170-177. doi:10.1093/gerona/glu223
13. Mair W, Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Ann Rev Biochem. 2008;77:727-754. doi:10.1146/ annurev.biochem.77.061206.171059
14. Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet. 2007;8:835-844. doi:10.1038/nrg2188
15. Liao CY, Johnson TE, Nelson JF. Genetic variation in responses to dietary restriction-an unbiased tool for hypothesis testing. Exp Gerontol. 2013;48:1025-1029. doi:10.1016/j.exger.2013.03.010
16. Miller RA, Harrison DE, Astle CM, et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014;13:468-477. doi:10.1111/acel.12194
17. Niedernhofer LJ, Garinis GA, Raams A, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006;444:1038-1043. doi:10.1038/nature05456
18. Baker DJ, Jeganathan KB, Cameron JD, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet. 2004;36:744-749. doi:10.1038/ng1382
19. Kudlow BA, Kennedy BK, Monnat RJ Jr. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol. 2007;8:394-404. doi:10.1038/nrm2161
20. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644-658. doi:10.1111/acel.12344
21. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342. doi:10.1038/nature05354
22. Kirkland JL, Tchkonia T. Clinical strategies and animal models for developing senolytic agents. Exp Gerontol. 2014;68:19-25. doi:10.1016/j. exger.2014.10.012
23. Huizer-Pajkos A, Kane AE, Howlett SE, et al. Adverse geriatric outcomes secondary to polypharmacy in a mouse model: the influence of aging. J Gerontol A Biol Sci Med Sci. 2016;71:571-577. doi:10.1093/gerona/glv046
24. Butler RN, Sprott R, Warner H, et al. Biomarkers of aging: from primitive organisms to humans. J Gerontol A Biol Sci Med Sci. 2004;59:B560-B567. doi:10.1093/gerona/59.6.b560
25. Wolf NS, Pendergrass WR. The relationships of animal age and caloric intake to cellular replication in vivo and in vitro: a review. J Gerontol A Biol Sci Med Sci. 1999;54:B502-B517. doi:10.1093/gerona/54.11.b502
26. Sonntag WE, Lynch CD, Cefalu WT, et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. J Gerontol A Biol Sci Med Sci. 1999;54:B521-B538. doi:10.1093/gerona/54.11.b502
27. Zhen X, Uryu K, Cai G, Johnson GP, Friedman E. Age-associated impairment in brain MAPK signal pathways and the effect of caloric restriction in Fischer 344 rats. J Gerontol A Biol Sci Med Sci. 1999;54:B539-B548. doi:10.1093/gerona/54.12.b539
28. Markowska AL, Breckler SJ. Behavioral biomarkers of aging: illustration of a multivariate approach for detecting age-related behavioral changes. J Gerontol A Biol Sci Med Sci. 1999;54:B549-B566. doi:10.1093/gerona/54.12.b549
29. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299-1307. doi:10.1172/ jci22475
30. Liu Y, Sanoff HK, Cho H, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8:439-448. doi:10.1111/j.1474-9726.2009.00489.x
31. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol. 2002;34:1401-1414. doi:10.1016/s1357-2725(02)00053-5
32. Acosta JC, O'Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008;133:1006-1018. doi:10.1016/j.cell.2008.03.038
33. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer. 2009;9:81-94. doi:10.1038/nrc2560
34. Dar AC, Das TK, Shokat KM, Cagan RL. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature. 2012;486:80-84. doi:10.1038/nature11127
35. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 1997;15:203-211. doi:10.1038/ sj.onc.1201178
36. Sanoff HK, Deal AM, Krishnamurthy J, et al. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst. 2014;106:dju057. doi:10.1093/jnci/dju057
37. Rosko A, Hofmeister C, Benson D, et al. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transplant. 2015;50:1379-1381. doi:10.1038/ bmt.2015.143
38. Nelson JA, Krishnamurthy J, Menezes P, et al. Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy. Aging Cell. 2012;11:916-918. doi:10.1111/j.1474-9726.2012.00856.x
39. Melk A, Schmidt BM, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant. 2009;9:114-123. doi:10.1111/j.1600-6143.2008.02500.x
40. McGlynn LM, Stevenson K, Lamb K, et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell. 2009;8:45-51. doi:10.1111/j.1474-9726.2008.00447.x
41. Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7:491-497. doi:10.1111/j.1474-9726.2008.00398.x
42. Gingell-Littlejohn M, McGuinness D, McGlynn LM, et al. Pre-transplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS One. 2013;8:e68133. doi:10.1371/journal.pone.0068133
43. Burd CE, Sorrentino JA, Clark KS, et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell. 2013;152:340-351. doi:10.1016/j.cell.2012.12.010
44. Tsygankov D, Liu Y, Sanoff HK, Sharpless NE, Elston TC. A quantitative model for age-dependent expression of the p16INK4a tumor suppressor. Proc Natl Acad Sci USA. 2009;106:16562-16567. doi:10.1073/ pnas.0904405106
45. Chrisp CE, Turke P, Luciano A, Swalwell S, Peterson J, Miller RA. Lifespan and lesions in genetically heterogeneous (four-way cross) mice: a new model for aging research. Vet Pathol. 1996;33:735-743. doi:10.1177/030098589603300620
46. Miller RA, Harrison DE, Astle CM, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66:191-201. doi:10.1093/gerona/glq178
47. Wilkinson JE, Burmeister L, Brooks SV, et al. Rapamycin slows aging in mice. Aging Cell. 2012;11:675-682. doi:10.1111/j.1474-9726.2012.00832.x
48. Nikolich-Zugich J, Goldman DP, Cohen PR, et al. Preparing for an aging world: engaging biogerontologists, geriatricians, and the society. J Gerontol A Biol Sci Med Sci. 2016;71:435-444. doi:10.1093/gerona/glv164